December 3, 2017 – CNS featured in the UCSD Guardian

Dr. Richard Smith, a local neurologist and director of the Center for Neurologic Study in La Jolla, told the Union-Tribune that the pathway for this new drug was etched a decade ago and was met with some skepticism initially. He stated that the “point that has drawn the most skepticism from peers has always been drug delivery.” This article can be found here.

© 2020 by Center for Neurologic Study.